Back From The Dead Biodexa Makes Bid For VarianBio
Months After Bioasis Merger Collapsed
Having just avoided going into administration, the firm formerly known as Midatech has pivoted its business model from a drug delivery company to a therapeutics player and has hit the acquisition trail.
